Update on biological actions of 1α,25(OH)2-vitamin D3 (rapid effects) and 24R,25(OH)2-vitamin D3

Molecular and Cellular Endocrinology

Volumn 197, Issue 1-2, 2002, Pages 1-13

  Norman, Anthony W ^a   Okamura, William H ^b   Bishop, June E ^a   Henry, Helen L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

1 ,25(OH)2D3; 24,25(OH)D3; Bone; Fracture healing; Rapid responses; Vitamin D

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 25 DIHYDROXYVITAMIN D3; CALCITRIOL; CALCIUM CHANNEL; CALCIUM ION; CELL NUCLEUS RECEPTOR; CHLORIDE; CHLORIDE CHANNEL; DRUG METABOLITE; LIGAND; MEMBRANE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; OXYGENASE; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR; 2 METHYL 1,25 DIHYDROXYVITAMIN D3; 2-METHYL-1,25-DIHYDROXYVITAMIN D3; 24,25 DIHYDROXYCOLECALCIFEROL; CALCITRIOL RECEPTOR; DRUG DERIVATIVE; VITAMIN D;

ARTICLE; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG INHIBITION; DRUG METABOLISM; DRUG RECEPTOR BINDING; ENZYME ACTIVATION; ENZYME ACTIVITY; FRACTURE HEALING; GENETIC TRANSCRIPTION; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TIBIA FRACTURE; ANIMAL; BIOLOGICAL MODEL; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; METABOLISM; PHYSIOLOGY; REVIEW; TISSUE DISTRIBUTION;

24,25-DIHYDROXYVITAMIN D 3; ANIMALS; CELL LINE; FRACTURE HEALING; LIGANDS; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE; RECEPTORS, CALCITRIOL; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; VITAMIN D;

EID: 0037195527     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(02)00273-3     Document Type: Article

References (69)

1. 3. J. Cell. Biochem. 56:1994;510-517.
2. 3 and is involved in the rapid actions of the hormone. Bone. 23:1998;S176.
3. 3-stimulated Egr induction. J. Biol. Chem. 270:1995;3642-3647.
4. 3 stimulates expression and translocation of protein kinase Cα and Cδ via a nongenomic mechanism and rapidly induces phosphorylation of a 33-kDa protein in acute promyelocytic NB4 cells. J. Biol. Chem. 271:1996;16090-16096.
5. 3 prime NB4 leukemia cells for monocytic differentiation via nongenomic signaling pathways, involving calcium and calpain. Endocrinology. 140:1999;4779-4788.
6. 3 is independent of nuclear receptor binding. J. Biol. Chem. 270:1995;15962-15965.
7. 3 primes acute promyelocytic cells for TPA-induced monocytic differentiation through both PKC and tyrosine phosphorylation cascades. Exp. Cell Res. 222:1996;61-69.
8. i. Am. J. Physiol. Gastrointest. Liver Physiol. 267:1994;G465-G475.
9. 2+-independent isoforms of protein kinase C in rat colonocytes. J. Clin. Invest. 95:1995;2215-2221.
10. Bouillon R., Okamura W.H., Norman A.W. Structure-function relationships in the vitamin D endocrine system. Endocr. Rev. 16:1995;200-257.
11. 2+ on phospholipid metabolism in dispersed porcine parathyroid cells. Endocrinology. 127:1990;2738-2743.
12. 3 on growth plate chondrocytes. J. Cell. Physiol. 176:1998;516-524.
13. 3 regulates cartilage and bone via autocrine and endocrine mechanisms. Steroids. 66:2001;363-374.
14. 3 metabolites modulate dihydropyridine-sensitive calcium currents in clonal rat osteosarcoma cells. J. Biol. Chem. 264:1989;20265-20274.
15. Canterbury J.M., Lerman S., Claflin A.J., Henry H.L., Norman A.W., Reiss E. Inhibition of parathyroid hormone secretion by 25-hydroxycholecalciferol and 24,25-dihydroxycholecalciferol in the dog. J. Clin. Invest. 61:1978;1375-1383.
16. Care A.D., Pickard D.W., Peacock M., Mawer B., Taylor C.M., Redel J., Norman A.W. Reduction of parathyroid hormone secretion by 24,25-dihydroxycholecalciferol (24,25-DHCC). Norman A.W., et al. Vitamin D: Biochemical, Chemical and Clinical Aspects Related to Calcium Metabolism. 1977;105-107 Walter de Gruyter, Berlin.
17. Castro-Errecaborde N., De la Piedra C., Rapado A., Alvarez-Arroyo M.V., Torres R., Traba M.L. Correlation between serum osteocalcin and 24,25-dihydroxyvitamin D levels in Paget's disease of bone. J. Clin. Endocrinol. Metab. 72:1991;462-466.
18. Chertow B.S., Baker G.R., Henry H.L., Norman A.W. The effects of vitamin D metabolites on bovine parathyroid hormone release in vitro. Am. J. Physiol. 238:1980;384-388.
19. 3 signaling in chick enterocytes: enhancement of tyrosine phosphorylation and rapid stimulation of mitogen-activated protein (MAP) kinase. J. Cell. Biochem. 69:1998;470-482.
20. 3-mediated effects on resting zone chondrocytes. J. Cell. Physiol. 182:2000;196-208.
21. 3-regulated expression of the eukaryotic genome. Nutr. Rev. 52:1994;376-382.
22. Henry H.L. Vitamin D. Goodman H.M., Handbook of Physiology. Section 7: The Endocrine System. 2000;699-718 Oxford, New York.
23. Henry H.L., Norman A.W. Vitamin D: two dihydroxylated metabolites are required for normal chicken egg hatchability. Science. 201:1978;835-837.
24. Henry H.L., Taylor A.N., Norman A.W. Response of chick parathyroid glands to the vitamin D metabolites, 1,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol. J. Nutr. 107:1977;1918-1926.
25. Hillman L.S., Slatopolsky E., Haddad J.G. Perinatal vitamin D metabolism. IV. Maternal and cord serum 24,25-dihydroxyvitamin D concentrations. J. Clin. Endocrinol. Metab. 47:1978;1073-1077.
26. 3: evidence for a non-nuclear membrane receptor in the chick tibial fracture-healing callus. Bone. 23:1998;141-146.
27. Kraft A.S., Baker V.V., May W.S. Bryostatin induces changes in protein kinase C location and activity without altering c-myc gene expression in human promyelocytic leukemia cells (HL-60). Oncogene. 1:1987;111-118.
28. Lange-Carter C.A., Pleiman C.M., Gardner A.M., Blumer K.J., Johnson G.L. A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf. Science. 260:1993;315-319.
29. 3 on the phosphoinositide metabolism in rat enterocytes. J. Biol. Chem. 264:1989;20403-20406.
30. 3. Calcif. Tissue Int. 50:1992;74-79.
31. 3. Calcif. Tissue Int. 50:1992;221-227.
32. Nemere I., Farach-Carson M.C. Membrane receptors for steroid hormones: a case for specific cell surface binding sites for vitamin D metabolites and estrogens. Biochem. Biophys. Res. Commun. 248:1999;443-449.
33. 3. Endocrinology. 115:1984;1476-1483.
34. 3 in basal-lateral membranes of chick intestinal epithelium and relationship to transcaltachia. J. Biol. Chem. 269:1994;23750-23756.
35. Noff D., Simkin A., Edelstein S. Effect of cholecalciferol derivatives on the mechanical properties of chick bones. Calcif. Tissue Int. 34:1982;501-505.
36. 3: a case study of transcaltachia (the rapid hormonal stimulation of intestinal calcium transport). Feldman D., Glorieux F.H., Pike J.W., Vitamin D. 1997;233-256 Academic Press, San Diego, CA.
37. 3: past, present, and future. J. Bone Miner. Res. 13:1998;1360-1369.
38. Norman A.W., Collins E.D. Vitamin D and gene expression. Moussa N.N., Berdanier C., Nutrient-Gene Interactions in Health and Disease. 2001;348-391 CRC Press, Orlando, FL.
39. 3. J. Nutr. 113:1983;2505-2515.
40. 3. J. Biol. Chem. 268:1993;20022-20030.
41. 3 indicates that the 6-s-cis conformation is preferred for rapid nongenomic biological responses and that neither 6-s-cis nor 6-s-trans locked analogs are preferred for genomic biological responses. Mol. Endocrinol. 11:1997;1518-1531.
42. 3-mediated signal transduction for genomic and rapid biological responses is dependent upon the conformation of the signaling ligand. Norman A.W., Bouillon R., Thomasset M., Vitamin D: Chemistry, Biology and Clinical Applications of the Steroid Hormone. 1997;331-338 University of California, Riverside, CA.
43. 3. J. Cell. Biochem. 74:1999;323-333.
44. 3 act as agonists for two different receptors in the vitamin D endocrine system to mediate genomic and rapid responses*(1). Steroids. 66:2001;147-158.
45. Okamura W.H., Midland M.M., Hammond M.W., Rahman N.A., Dormanen M.C., Nemere I., Norman A.W. Chemistry and conformation of vitamin D molecules. J. Steroid Biochem. Mol. Biol. 53:1995;603-613.
46. Ornoy A., Goodwin D., Noff D., Edelstein S. 24,25-Dihydroxyvitamin D is a metabolite of vitamin D essential for bone formation. Nature. 276:1978;517-519.
47. 3 analogue toward vitamin D receptor function. J. Biol. Chem. 274:1999;32376-32381.
48. Pang L., Sawada T., Decker S.J., Saltiel A.R. Inhibition of MAP kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J. Biol. Chem. 270:1995;13585-13588.
49. 3. J. Bone Miner. Res. 14:1999;856-867.
50. Pelech S.L., Sanghera J.S. Mitogen-activated protein kinases: versatile transducers for signaling. Trends Biochem. Sci. 17:1992;233-238.
51. Roberts J.R., Nelson B., Marton M.J., Stoughton R., Meyer M.R., Bennett H.A., He Y.D., Dai H., Walker W.L., Hughes T.R., Tyers M., Boone C., Friend S.H. Signaling and circuitry of multiple MAPK pathways revealed by a matrix of global gene expression profiles. Science. 287:2000;873-880.
52. Rochel N., Wurtz J.M., Mitschler A., Klaholz B., Moras D. The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol. Cell. 5:2000;173-179.
53. 3 regulation of stromelysin-1 (MMP-3) in chondrocyte cultures is mediated by protein kinase C. J. Cell. Physiol. 168:1996;570-579.
54. 2 specific activities. Endocrinology. 123:1988;2878-2884.
55. 3 mediates its membrane receptor-dependent effects on protein kinase C and alkaline phosphatase via phospholipase A(2) and cyclooxygenase-1 but not cyclooxygenase-2 in growth plate chondrocytes. J. Cell. Physiol. 182:2000;390-401.
56. 3 in cardiac muscle. Mol. Cell. Endocrinol. 82:1991;229-235.
57. 3 levels are correlated with the healing process after chick tibial fracture. J. Bone Miner. Res. 12:1997;598-606.
58. 3 receptor/binding protein in a membrane fraction isolated from a chick tibial fracture-healing callus. Biochem. Biophys. Res. Commun. 225:1996;203-208.
59. 3 metabolite for both normal bone integrity and healing of tibial fracture in chicks. Endocrinology. 138:1997;3864-3872.
60. 3 increases membrane associated protein kinase C in MDBK cells. Cell. Signal. 4:1992;99-109.
61. 3. J. Biol. Chem. 270:1995;6639-6643.
62. 3 in promyelocytic NB4 leukemia cells: a structure-function study. Endocrinology. 139:1998;457-465.
63. St. Arnaud R., Arabian A., Glorieux F.H. Abnormal bone development in mice deficient for the vitamin D 24-hydroxylase gene. J. Bone Miner. Res. 11:1996;S126.
64. St. Arnaud R., Arabian A., Travers R., Barletta F., Raval-Pandya M., Chapin K., Depovere J., Mathieu C., Christakos S., Demay M.B., Glorieux F.H. Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D. Endocrinology. 141:2000;2658-2666.
65. 3 on cytosolic calcium in dispersed parathyroid cells. Kidney Int. 33:1988;850-854.
66. 2 and phospholipase C in growth zone chondrocytes. J. Bone Miner. Res. 13:1998;559-569.
67. 3: role of protein kinase C translocation. Biochem. Biophys. Res. Commun. 163:1989;1517-1522.
68. 3-mediated stimulation of outward anionic currents in osteoblast-like ROS 17/2.8 cells. Biochem. Biophys. Res. Commun. 225:1996;551-556.
69. 3 of whole cell chloride currents in osteoblastic ROS 17/2.8 cells: a structure-function study. J. Biol. Chem. 272:1997;22617-22622.